Acute Erythroleukemia

Search Trials
Busulfan, Etoposide, and Total-Body Irradiation Followed by Autologous Stem Cell Transplant and Aldesleukin in Treating Patients With Acute Myeloid Leukemia in First Remission
Status:
Active, not recruiting
Last Changed:
Feb 21, 2022
First Changed:
Sep 24, 2007
Disease(s):
Leukemia
Intervention(s):
aldesleukinfilgrastimbusulfancytarabineetoposideidarubicinautologous hematopoietic stem cell transplantationbone marrow transplantationperipheral blood stem cell transplantationtotal-body irradiation
Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Status:
Active, not recruiting
Last Changed:
Aug 18, 2021
First Changed:
Apr 2, 2008
Disease(s):
Leukemia
Intervention(s):
cytarabinedaunorubicinmidostaurinplacebodexamethasone acetate
Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Status:
Unknown status
Last Changed:
Oct 23, 2018
First Changed:
Jun 30, 2010
Disease(s):
Leukemia
Intervention(s):
cytarabineetoposideeverolimusidarubicinmitoxantrone hydrochloride
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia
Status:
Active, not recruiting
Last Changed:
Aug 17, 2021
First Changed:
May 12, 2009
Disease(s):
Leukemia
Intervention(s):
gene expression analysismolecular genetic techniquepolymorphism analysisprotein expression analysisdiagnostic laboratory biomarker analysis
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia
Status:
Unknown status
Last Changed:
Nov 6, 2013
First Changed:
Apr 13, 2004
Disease(s):
Leukemia
Intervention(s):
lintuzumabcytarabineetoposidemitoxantrone hydrochloride

Connect. Empower. Inspire.